Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
PGG Wrightson (PGW) / FY24

PBT down 78% and the dividend cancelled at PGW

FY24 met the $43m EBITDA guide but H2 NPAT turned negative and the cash rebound was driven by a $17.4m working-capital release.

Primary Industries / Rural services

PGW revenue trajectory

Revenue context before the current result.

↗
Loading chart...
HY26 was $619.4m, versus $975.3m in FY25.

PGW EBITDA margin

EBITDA margin across covered periods.

↗
Loading chart...
HY26 was 7.4%, versus 5.8% in FY25.

PGW operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
HY26 was -$49.9m, versus $12.4m in FY25.

PGW working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
HY26 was $53.4m, versus $23.8m in FY25.
Release date
13 August 2024
Published
21 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

FY24 vs FY23

Revenue

$915.9m

-6.1% ↓ vs $975.7m

EBITDA

$44.2m

-27.8% ↓ vs $61.2m

Net profit after tax

$3.1m

-82.3% ↓ vs $17.5m

Net cash inflow from operating activities

$57.7m

+126.3% ↑ vs $25.5m

Declared dividend per share

—

— vs 10.0c

Operating profit

$15.4m

-54.2% ↓ vs $33.5m

Profit before tax

$5.3m

-77.8% ↓ vs $23.9m

Cash and cash equivalents

$3.8m

-18.5% ↓ vs $4.6m

What changed

Profit before tax collapsed 77.8% to $5.3m and net profit after tax fell 82.3% to $3.1m on revenue of $915.9m, down 6.1%

Operating EBITDA fell 27.8% to $44.2m, in line with the company's revised guidance of around $43m. The board declared no final dividend for FY24, against a 10 cent prior-year final.

Net cash inflow from operating activities moved the other way, rising 126.3% to $57.7m, with the second-half implied OCF of $118.6m more than reversing the $60.9m HY24 outflow. Capex stepped up 33.0% to $22.8m. Gross borrowings reduced to $63.0m from $70.0m, but net debt to EBITDA rose to 1.34x from 1.07x as the EBITDA decline outweighed the debt reduction.

What matters

The operating deterioration is sharper than EBITDA alone implies, and tax distorts the bottom line

  • Operating profit fell 54.2% to $15.4m and PBT fell 77.8%, so the drop-through from a 6.1% revenue decline was severe. The effective tax rate widened to 42.5% from 26.8%, which means PBT is the cleaner operating read at -77.8%; the headline NPAT decline of 82.3% overstates the operating slip by roughly 4.5 percentage points.

  • The cash-flow rebound is balance-sheet-assisted, not earnings-driven. Working capital fell $17.4m as inventories declined $12.3m (-11.5%) and trade debtors fell $8.2m (-7.0%). Free cash flow before leases of $34.9m sits at n/m of NPAT, a ratio that flags the gap between the cash optics and the underlying earnings result rather than confirming a durable cash quality improvement.

  • The dividend cancellation reframes the leverage signal. With $57.7m of OCF in hand, the choice not to pay any final dividend (against a 43.1% prior-year payout ratio on NPAT) suggests management is prioritising debt and balance-sheet capacity over distribution, consistent with leverage drifting up on a net-debt-to-EBITDA basis. ROE fell to 1.9% from 10.4%.

Expectations

PGW met its revised FY24 Operating EBITDA forecast of around $43m, delivering $44.2m

That removes one source of disappointment, but the shape of the year is unhelpful: HY24 NPAT was $9.9m and full-year NPAT is $3.1m, implying a second-half NPAT of approximately -$6.9m. The deterioration accelerated into H2 as sheep-meat farmgate weakness, elevated rates and on-farm cost pressures bit harder.

No FY25 guidance is supplied in this release. The release commentary cites weak China sheep-meat demand, elevated interest rates and clients deferring spend and reducing debt, which means the H2 run-rate, not the full-year average, is the more relevant base for thinking about FY25.

Quality of result

Cash quality this year is timing-driven rather than earnings-driven

OCF/EBITDA jumped to 130.7% from 41.7%, but the swing is largely accounted for by the $17.4m reduction in operating working capital and the H1-to-H2 reversal of the seasonal cash cycle. Receivable days (43.6) and inventory days (37.9) are both modestly below prior year, so the working capital release looks at least partly volume- and demand-driven rather than collections-driven, which limits the read-through to FY25 cash flow.

Earnings quality weakened on multiple axes. Both reportable segments contributed: Retail & Water result fell to $41.0m from $54.1m, and Agency result fell to $12.3m from $16.1m, with shares of group revenue largely unchanged. Capex intensity rose to 2.5% of revenue from 1.8%, so the FCF figure also benefits from a higher denominator on the cash side without any matching uplift in earnings power. The cleaner read is that the underlying business produced materially less profit on slightly less revenue, and the cash result borrowed from balance-sheet contraction.

Unresolved

Open questions

What is management's FY25 expectation for Operating EBITDA given an H2 NPAT run-rate of roughly -$6.9m?
How much of the $17.4m working-capital release should be treated as one-off, and what reverses if client demand recovers?
Why did the effective tax rate widen to 42.5%, and is that a recurring feature of the current earnings mix?
What conditions would the board need to see to reinstate a dividend, given net debt to EBITDA has already drifted up to 1.34x?
How is the step-up in capex to $22.8m being directed across Retail & Water versus Agency, and what return profile is expected?

This briefing cannot assess the durability of FY25 trading conditions, the trajectory of farmgate prices, or the timing of any dividend reinstatement.

Chat

Ask about PGW FY24

Ask follow-up questions about PGG Wrightson's FY24 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about PGW FY24

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about PGG Wrightson's FY24 result.

What is management's FY25 expectation for Operating EBITDA given an H2 NPAT run-rate of roughly -$6.9m?Why does "The operating deterioration is sharper than EBITDA alone implies, and tax distorts the bottom line" matter?How strong was the cash and earnings quality in FY24?What should I watch next for PGW after FY24?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

NZX Template Results Announcement 30 June 2024

FY24 / results announcement↗

PGW Financial Statements_30 June 2024

FY24 / financial report↗

PGW Results Announcement 30 June 2024

FY24 / results release↗

Prior comparable period

PGW Financial Statements for Year Ended 30 June 2023

FY23 / financial report↗

PGW Results Announcement FY23

FY23 / results announcement↗

PGW Results Announcement FY23

FY23 / results release↗

Interim context

PGW Half Year Results Announcement Details

HY24 / financial report↗

Release context

PGW Guidance Update

FY24 / commentary↗

PGW HY Results Presentation Deck_31 December 2023

FY24 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 4.5pp, with a distortion flag in the result.

→

Cash conversion quality

This result converted 130.7% of EBITDA to operating cash flow, +89.0pp versus the prior comparable period.

→

Leverage and balance-sheet risk

Net debt / EBITDA is 1.34x, +0.27x versus the prior comparable period.

→

ROE and capital efficiency

ROE was 1.9%, -8.5pp versus the prior comparable period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when PGW publishes next

Get the next PGG Wrightson briefing and related NZX reporting-season updates by email.